If you take a GLP-1 and have heart surgery planned, tell your surgeon and anesthesia team which medicine you take and when you last took it. They can tell you whether to continue or pause it. The American Diabetes Association advises an individualized plan based on why you take the medicine, symptoms, and the type and urgency of surgery and anesthesia [4].
Why the anesthesia team needs to know
Our guide to GLP-1 medicines before surgery explains how the team weighs delayed stomach emptying and blood sugar management. Wegovy’s U.S. label reports rare cases of aspiration during general anesthesia or deep sedation despite fasting. The label says available data are insufficient to determine whether changing fasting instructions or temporarily stopping the drug reduces retained stomach contents [5].
What trials of liraglutide during heart surgery found
In GLOBE, researchers randomly assigned 278 cardiac surgery patients to liraglutide or placebo. They analyzed the 261 participants who received at least one study injection. Extra insulin was needed during surgery by 55 of 129 patients (43%) on liraglutide and 80 of 132 (61%) on placebo. The trial excluded people already taking a GLP-1, so it cannot answer whether to continue an existing prescription[2].
Our guide to GLP-1 medicines and low blood sugar explains why other medicines matter when interpreting hypoglycemia. In GLOLIA, 70 people with type 2 diabetes undergoing elective cardiac surgery were assigned to insulin plus liraglutide or insulin alone. The combination improved a measure of how close glucose stayed to the treatment target and required fewer insulin adjustments [3].
What the pooled evidence says about complications
A 2026 review identified seven reports from four randomized trials with 446 patients. These trials compared perioperative liraglutide with placebo or usual insulin-based care. There was one death in 161 people receiving liraglutide and three in 160 controls among studies reporting 30-day mortality. The risk ratio was 0.42, with a 95% confidence interval of 0.06–2.81 [1].
The estimates for postoperative complications, cardiac events, low blood sugar and nausea or vomiting were also inconclusive. For example, the risk ratio for nausea or vomiting was 3.01, with a 95% confidence interval of 0.26–35.27[1].